Medical Device manufacturer EndoGastric Solutions Inc. will pay Uncle Same $5.25 million to settle allegations that it defrauded Medicare by misleading health care providers about how to bill Medicare and for paying kickbacks.
EndoGastric sells a device called EsophyX to treat gastroesophageal reflux. The Government alleges that EndoGastric Solutions knowing caused health care providers to...
Continue reading…
Category: Pharmaceutical
F.D.A. re-examining drugs manufactured in India over safety issues
The Food and Drug Administration is now concerned about the safety of drugs manufactured in India and is examining the products flooding the U.S. markets as a result of safety lapses, falsified drug test results and the selling of fake medicines.
India's pharmaceutical companies supplies over 40 percent of the over-the-counter medicines in the U.S....
Continue reading…
Celgene charged with fraudulent promotion of cancer drugs Thalidomid and Revlimid
Celegene Corporation has been charged by whistleblower former company Salesperson Beverly Brown, with fraudulently promoting and marketing its cancer drugs Thalidomid and Revlimid in ways not approved by the FDA.
Ms. Brown, said in a Federal Court Complaint that patients and medical advisors were denied appropriate warnings provided in a package insert.
DaVita HealthCare pays $389 million to settle kickback investigation by Uncle Sam
DavIta HealthCare Partners is paying $389 million to resolve civil and criminal anti-kickback investigations and will end joint ventures with kidney doctors involving 28 Dialysis clinics.
Providing kidney dialysis treatments is a significant profit maker for the healthcare industry. Patients can go wherever they wish to receive the treatment. But most go to clinics where...
Continue reading…
Medical device company pays $40.1 Million to Uncle Sam for promoting unapproved surgical prep solution
Medical device manufacturer CareFusion will pay $40.1 million to settle a False Claims Act whistleblower case for improperly promoting and marketing its surgical preparation solution Chloraprep. It also concealed kickbacks to a doctor who promoted the drug says the DOJ.
Chloraprep was promoted for the surgical prepration for use with intravenous prepration and suture care,...
Continue reading…
CareFusion Corp. med tech company pays $40.1 to settle whistleblower suit over kickbacks and off label sales
Carefusion will pay $40.1 million to settle a government lawsuit and whistleblower allegations under the False Claims Act, that the company paid kickbacks to increase sales of its pre-surgical skincare product ChloraPrep.
In addition, the company is alleged to have promoted the product unlawfully for uses not approved by the FDA. In this situation it...
Continue reading…
8 Johnson & Johnson whistleblowers get more than $20 million each from $2.2 Billion fine
The whistleblowers at Johnson & Johnson who helped the federal government obtain $2.2 billion in fines from the company for bribing physicians, pharmacies and long term care managers to encourage sales of antipsychotic drugs will receive more than $20 million each.
The first who filed will each get $29 million from the settlement and the...
Continue reading…
DePuy ASR hip settlement requires registration by January 6
Individuals who had problems with a DePuy ASR hip replacement resulting in the need for revision surgery must register by January 6 to be part of the settlement program announced in November.
There are about 12,000 hip replacement lawsuits pending in state and federal courts around the country, filed following the recall of the DePuy...
Continue reading…
HHS Targets fraudulent double billing Medicare for Herceptin breast cancer drug by hospitals
The United States Health and Human Services (HHS) watchdog office is investigating a number of cancer centers nationwide for double billing Medicare and Medicaid for the costly breast cancer drug Herceptin.
After an extensive statistical review. HHS says that many doctors and hospitals and doctors have been billing the government for a full vial of...
Continue reading…
Johnson & Johnson whistleblowers to receive $168 million for revealing fraud
Johnson & Johnson's $2.2 billion settlement for marketing drugs for unapproved uses and giving kickbacks to doctors has resulted in a payment of $168 million to the whistleblowers who revealed the fraud.
This whistleblower award is one of the largest in history.
